151 related articles for article (PubMed ID: 19178675)
41. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
42. Factors affecting the unexpected failure of DCE-MRI to determine the optimal biological dose of the vascular targeting agent NGR-hTNF in solid cancer patients.
Desar IM; van Herpen CM; van Asten JJ; Fiedler W; Marreaud S; Timmer-Bonte JN; ter Voert EG; Lambiase A; Bordignon C; Heerschap A; van Laarhoven HW
Eur J Radiol; 2011 Dec; 80(3):655-61. PubMed ID: 20863638
[TBL] [Abstract][Full Text] [Related]
43. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
44. Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients.
Nielsen T; Murata R; Maxwell RJ; Stødkilde-Jørgensen H; Ostergaard L; Horsman MR
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):859-66. PubMed ID: 18164835
[TBL] [Abstract][Full Text] [Related]
45. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
[TBL] [Abstract][Full Text] [Related]
46. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
47. Contrast enhancement and tissues classification of breast MRI using Kalman filter-based linear mixing method.
Yang SC; Wang CM; Hsu HH; Chung PC; Hsu GC; Juan CJ; Lo CS
Comput Med Imaging Graph; 2009 Apr; 33(3):187-96. PubMed ID: 19135862
[TBL] [Abstract][Full Text] [Related]
48. Dynamic contrast-enhanced breast MR imaging.
Moon M; Cornfeld D; Weinreb J
Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?
Alic L; van Vliet M; van Dijke CF; Eggermont AM; Veenland JF; Niessen WJ
Phys Med Biol; 2011 Mar; 56(6):1601-16. PubMed ID: 21335648
[TBL] [Abstract][Full Text] [Related]
50. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
[TBL] [Abstract][Full Text] [Related]
51. Cancer models-multiparametric applications of clinical MRI in rodent hepatic tumor model.
Chen F; De Keyzer F; Ni Y
Methods Mol Biol; 2011; 771():489-507. PubMed ID: 21874495
[TBL] [Abstract][Full Text] [Related]
52. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
53. Pathologic significance of the "dural tail sign".
Rokni-Yazdi H; Azmoudeh Ardalan F; Asadzandi Z; Sotoudeh H; Shakiba M; Adibi A; Ayatollahi H; Rahmani M
Eur J Radiol; 2009 Apr; 70(1):10-6. PubMed ID: 18294796
[TBL] [Abstract][Full Text] [Related]
54. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
[TBL] [Abstract][Full Text] [Related]
55. Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability.
Spilker ME; Seng KY; Yao AA; Daldrup-Link HE; Shames DM; Brasch RC; Vicini P
J Magn Reson Imaging; 2005 Oct; 22(4):549-58. PubMed ID: 16161077
[TBL] [Abstract][Full Text] [Related]
56. Magnetic resonance imaging in peripheral lung adenocarcinoma: correlation with histopathologic features.
Tanaka R; Horikoshi H; Nakazato Y; Seki E; Minato K; Iijima M; Kojima M; Goya T
J Thorac Imaging; 2009 Feb; 24(1):4-9. PubMed ID: 19242296
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of soft tissue lesions affecting the masticator space with dynamic contrast enhanced MRI].
Tang WQ; Le WJ; Wang PZ; Shi HM; Yu Q
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):711-5. PubMed ID: 24495719
[TBL] [Abstract][Full Text] [Related]
58. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience.
Baxter S; Wang ZJ; Joe BN; Qayyum A; Taouli B; Yeh BM
J Magn Reson Imaging; 2009 Jun; 29(6):1317-22. PubMed ID: 19472388
[TBL] [Abstract][Full Text] [Related]
59. [MRI monitoring of cerebral spinal fluid metastasis in rabbit model].
Zhang GX; Li KA; Zhao JL; Zhang F; Hu YS; Li YJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3369-73. PubMed ID: 19257973
[TBL] [Abstract][Full Text] [Related]
60. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
